ZE50-0134

· Lomond Therapeutics Holdings, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZE50-0134, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers [Phase 1]

See pricing